| NCT06944834 | A Study on the Safety and Functionality of the Implantable Wireless Brain-Computer Interfaces for Motor Rehabilitation | Shanghai StairMed Technology Co., Ltd. | | - Age 18 - 65 yrs
- Level C1-S5
AIS - ≥ 1 years
- NOT have metal implants or devices (e.g., cochlear implants, pacemakers, neurostimulators, defibrillators), except for dental implants or other implants deemed non-interfering
- Have an expected lifespan of at least 12 months
| Recruiting soon | 5 | NA | Surgery | General health | - Adverse Events (AEs)
- American Spinal Injury Association Impairment Scale (AIS)
- Feasibility
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Patient Health Questionnaire-9 (PHQ-9)
- Short Form 36 (SF-36)
| 6 months | 01 April 2025 | 25 April 2025 | 1 | |
| NCT06886386 | TsDCS and Physical Therapy After Incomplete Spinal Cord Injury | Universidade Federal de Pernambuco | | - Age 18 - 55 yrs
- Level C1-S5
AIS - ≥ 1 years
| By invitation | 20 | NA | Technology | Arm/hand function | - American Spinal Injury Association Impairment Scale (AIS)
- Ashworth and Modified Ashworth Scale (MAS)
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Spinal Cord Independence Measure (SCIM)
| 1 month | 03 March 2025 | 20 March 2025 | 1 | |
| NCT07139496 | Combined Injury-site & Lumbosacral Epidural Spinal Cord Stimulation | The University of Hong Kong | | - Age 18 - 70 yrs
- Level C1-S5
AIS A, B- ≥ 2 years
| Recruiting | 5 | NA | Technology | Standing/walking/mobility | - Depression Anxiety Stress Scale-21 (DASS-21)
- Pain Numeric Rating Scale (NRS)
- Short Form 36 (SF-36)
- Walking Index for Spinal Cord Injury (WISCI) and WISCI II
| 1 year | 01 September 2025 | 24 August 2025 | 1 | |
| NCT07002437 | Hypoxia Pathways for Early Recovery After Spinal Cord Injury | University of Florida | | - Age 18 - 70 yrs
- Level C1-T6
AIS A, B, C, D- 1 months - 6 months
| Recruiting | 18 | NA | Drug | General health | - Hand-Held Myometery / Dynamometry
| 3 days | 20 November 2025 | 03 June 2025 | 2 | |
| NCT06976229 | Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | | - Age 18 - 65 yrs
- Level C4-L2
AIS A, B, C- 14 days - 60 days
| Recruiting | 12 | PHASE1 | Biological/cell based | General health | - Adverse Events (AEs)
- American Spinal Injury Association Impairment Scale (AIS)
- Feasibility
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Spinal Cord Independence Measure (SCIM)
| 1 year | 02 July 2025 | 16 May 2025 | 1 | |
| NCT06723561 | Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury | Medical College of Wisconsin | | - Age ≥ 18 yrs
- Level C1-T12
AIS - ≥ 6 months
- experience central neuropathic pain, based on evaluation by a Physical medicine and rehabilitation physician
| Recruiting | 10 | PHASE2 | Drug | Mental health and psychosocial factors | - Neuropathoc Pain Symptom Inventory (NPSI)
- Quality of Life Index (QLI) - SCI Version
| 12 weeks | 01 February 2025 | 09 December 2024 | 1 | |
